Serum Glycerophospholipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

被引:21
作者
Gai, Xiaoyan [1 ]
Guo, Chenglin [1 ]
Zhang, Linlin [1 ]
Zhang, Lijiao [1 ]
Abulikemu, Mairipaiti [1 ]
Wang, Juan [1 ]
Zhou, Qingtao [1 ]
Chen, Yahong [1 ]
Sun, Yongchang [1 ]
Chang, Chun [1 ]
机构
[1] Peking Univ Third Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
glycerophospholipids; metabolomics; chronic obstructive pulmonary disease; acute exacerbation of chronic obstructive pulmonary disease; inflammatory subtype; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; SURFACTANT; COPD; MS;
D O I
10.3389/fphys.2021.646010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Studies have shown that glycerophospholipids are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). This study adopted targeted metabolomic analysis to investigate the changes in serum glycerophospholipids in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and their differential expression in patients with different inflammatory subtypes. Patients with AECOPD admitted between January 2015 and December 2017 were enrolled, and their clinical data were collected. The patients' gender, age, body mass index, and lung function were recorded. Routine blood and induced sputum tests were performed. Liquid chromatography-mass spectrometry was used to detect the serum glycerophospholipid metabolic profiles and to analyze the metabolic profile changes between the acute exacerbation and recovery stages as well as the differences between different inflammatory subtypes. A total of 58 patients were hospitalized for AECOPD, including 49 male patients with a mean age of 74.8 +/- 10.0 years. In the metabolic profiles, the expression of lysophosphatidylcholine (LPC) 18:3, lysophosphatidylethanolamine (LPE) 16:1, and phosphatidylinositol (PI) 32:1 was significantly reduced in the acute exacerbation stage compared to the recovery stage (P < 0.05). The three glycerophospholipids were used to plot the receiver operating characteristic curves to predict the acute exacerbation/recovery stage, and the areas under the curves were all above 70%. There were no differential metabolites between the two groups of patients with blood eosinophil percentage (EOS%) >= 2% and <2% at exacerbation. The expression of LPC 18:3, LPE 16:1, and PI 32:1 was significantly reduced in the acute exacerbation stage compared to the recovery stage in the inflammatory subtype with blood EOS <2% (P < 0.05). Abnormalities in the metabolism of glycerophospholipids may be involved in the onset of AECOPD, especially in the non-eosinophilic subtype.
引用
收藏
页数:8
相关论文
共 31 条
[1]   Characteristics and Outcomes of Critically III Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Australia and New Zealand [J].
Berenyi, Freya ;
Steinfort, Daniel P. ;
Abdelhamid, Yasmine Ali ;
Bailey, Michael J. ;
Pilcher, David, V ;
Bellomo, Rinaldo ;
Finnis, Mark E. ;
Young, Paul J. ;
Deane, Adam M. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (06) :736-745
[2]   MALDI imaging MS of phospholipids in the mouse lung [J].
Berry, Karin A. Zemski ;
Li, Bilan ;
Reynolds, Susan D. ;
Barkley, Robert M. ;
Gijon, Miguel A. ;
Hankin, Joseph A. ;
Henson, Peter M. ;
Murphy, Robert C. .
JOURNAL OF LIPID RESEARCH, 2011, 52 (08) :1551-1560
[3]  
Cao W.L., 2006, CHIN J RESP CRIT CAR, V5, P93
[4]   Lipid metabolism in chronic obstructive pulmonary disease [J].
Chen, Haipin ;
Li, Zhouyang ;
Dong, Lingling ;
Wu, Yinfang ;
Shen, Huahao ;
Chen, Zhihua .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 :1009-1018
[5]   MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis [J].
Chong, Jasmine ;
Soufan, Othman ;
Li, Carin ;
Caraus, Iurie ;
Li, Shuzhao ;
Bourque, Guillaume ;
Wishart, David S. ;
Xia, Jianguo .
NUCLEIC ACIDS RESEARCH, 2018, 46 (W1) :W486-W494
[6]   Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD [J].
Cruickshank-Quinn, Charmion I. ;
Jacobson, Sean ;
Hughes, Grant ;
Powell, Roger L. ;
Petrache, Irina ;
Kechris, Katerina ;
Bowler, Russell ;
Reisdorph, Nichole .
SCIENTIFIC REPORTS, 2018, 8
[7]  
Drzazga A, 2014, ACTA POL PHARM, V71, P887
[8]   Lipid-based biomarkers for CVD, COPD, and aging - A translational perspective [J].
Ekroos, Kim ;
Lavrynenko, Oksana ;
Titz, Bjoern ;
Pater, Calin ;
Hoeng, Julia ;
Ivanov, Nikolai V. .
PROGRESS IN LIPID RESEARCH, 2020, 78
[9]   Lysophosphatidylethanolamine acyltransferase 2 (LPEAT2) incorporates DHA into phospholipids and has possible functions for fatty acid-induced cell death [J].
Eto, Miki ;
Shindou, Hideo ;
Yamamoto, Shota ;
Tamura-Nakano, Miwa ;
Shimizu, Takao .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (01) :246-252
[10]   Metabolomic Analysis of Serum Glycerophospholipid Levels in Eosinophilic and Neutrophilic Asthma [J].
Gai Xiao Yan ;
Zhang Li Jiao ;
Chang Chun ;
Guo Cheng Lin ;
Abulikemu, Mairipaiti ;
Li Wen Xiong ;
Wang Juan ;
Yao Wan Zhen ;
Zhang Xu .
BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2019, 32 (02) :96-106